Blodprøver for lang levetid: glykank, IGF-1 og NAD

Hvilke blodprøver for lang levetid kan og ikke kan fortelle deg

I vår analyse av 2M+ opplastinger av blodprøver er det pasientene som har mest nytte ikke de som jakter på én enkelt aldersscore. Det er de som sammenligner ApoB, HbA1c, kreatinin, ALT, ferritin, hs-CRP og vitamin D over 6–24 måneder, og deretter spør hva som endret seg og hvorfor.

Kantesti er en AI-blodprøveanalysator som leser livslengdepaneler i klinisk kontekst, inkludert rutinemessig kjemi, hormoner og nyere biomarkører som glycan age, IGF-1 og NAD når de fremkommer i en rapport. Våre kliniske standarder er beskrevet i medisinsk validering, fordi en livslengderesultat uten sikkerhetsrammer kan føre folk mot unødvendige kosttilskudd eller gjentatt testing.

Thomas Klein, MD, ser ett gjentakende mønster i gjennomganger: en 46-åring med en perfekt score for biologisk alder, men med en ApoB på 128 mg/dL, trenger fortsatt en diskusjon om kardiovaskulær risiko. For et bredere evidensbasert utgangspunkt, vår veiledning til livslengdemarkører forklarer hvorfor standardprøver vanligvis kommer først.

Glykanalder-test: hva den menneskelige evidensen egentlig viser

IgG N-glykanner er sukkerstrukturer som er festet til immunglobulin G, og mønstrene deres endrer seg med alder. Krištić et al. rapporterte i Journal of Gerontology at glykanner kan fungere som biomarkører for kronologisk og biologisk alder, men det betyr ikke at et 7-års glycan-gap predikerer nøyaktig 7 tapte leveår (Krištić et al., 2014).

Den praktiske tolkningen er smalere. En høyere glycan age kan passe med høy hs-CRP over 3 mg/L, sentral adipositet, insulinresistens, røykeeksponering eller ubehandlet inflammatorisk sykdom; den bør ikke brukes alene til å diagnostisere akselerert aldring.

Vi ser også at konteksten rundt kjønnshormoner betyr noe. Rundt overgangsalderen kan IgG-glykosylering skifte på måter som overlapper med metabolske og inflammatoriske endringer, og det er derfor pasienter som sammenligner et resultat for glycan age ofte har nytte av å lese det ved siden av vår inflammaging-biomarkør veiledning, i stedet for å behandle det som en dom.

Slik leser du glykanalder ved siden av inflammasjon og metabolisme

hs-CRP-båndene for kardiovaskulær risiko leses ofte som under 1 mg/L for lav risiko, 1–3 mg/L for intermediær risiko og over 3 mg/L for høyere risiko når akutt infeksjon er utelukket. Hvis noen har hs-CRP på 9 mg/L etter en luftveisinfeksjon, er et glykanalder-resultat innhentet samme uke vanskelig å tolke.

Et vanlig scenario: En 52 år gammel maratonløper får en eldre glykanalder og får panikk. Hvis samme panel viser CK på 900 U/L etter et løp, AST på 89 U/L, normal ALT og normalt bilirubin, kan den biologiske alder-skåren være forurenset av treningsstress heller enn en kronisk nedgang.

For pasienter som ønsker en lesning med fokus på inflammasjon, start med om resultatet er CRP eller hs-CRP, fordi analysene besvarer ulike spørsmål. Vår veiledning til CRP og hs-CRP forklarer hvorfor et mildt, kronisk signal og et akutt immunrespons ikke bør blandes sammen.

IGF-1 blodprøve for lang levetid: hvorfor lavt ikke alltid er bedre

IGF-1 synker normalt med alder, og referanseintervaller for voksne er svært avhengige av alder. Et resultat på 220 ng/mL kan være normalt for en 25-åring, men høyt for noen 75-åringer, avhengig av analysen og lokale intervaller.

Milman et al. rapporterte i Aging Cell at lavere IGF-1 var assosiert med overlevelse hos noen personer med eksepsjonell lang levetid, særlig i spesifikke genetiske kontekster, men det gir ikke grunnlag for å presse IGF-1 under referanseområdet hos hverdags-pasienter (Milman et al., 2014). Klinikere blir bekymret når lav IGF-1 opptrer sammen med lav albumin under 3,5 g/dL, utilsiktet vekttap eller lavt testosteron.

Hvis IGF-1 er over aldersjustert øvre grense, blir spørsmålet klinisk: hodepine, endringer i kjeve eller ringstørrelse, svetting, søvnapné og forhøyet fastende glukose endrer risikoprofilen. Vår testing av veksthormon guide explains why repeat IGF-1 and specialist evaluation can matter more than a single value.

IGF-1-områder, ny testing og konfunderende faktorer

Fasting is not always required for IGF-1, but timing and physiology still matter. Severe calorie restriction, uncontrolled diabetes, liver dysfunction and low protein intake can suppress IGF-1 even when growth hormone secretion is not the main problem.

When I review an IGF-1 of 48 ng/mL in a 68-year-old with albumin of 3.1 g/dL and 7 kg weight loss, I do not call that a longevity advantage. The more immediate concern is nutrition, inflammation, liver synthesis or an endocrine axis problem.

Do not compare IGF-1 across labs as if every method is interchangeable. Unit conversions, binding protein effects and assay calibration can make year-to-year results look changed, so read our faste versus ikke-faste guide before over-reading a small shift.

NAD-blodprøve: lovende biologi, svake kliniske grenseverdier

NAD is central to redox biology, mitochondrial function and sirtuin-related pathways, but the blood test is technically fragile. Sample temperature, processing delay and whether the lab measures NAD+, NADH, NR, NMN or related metabolites can change the answer.

Martens et al. showed in Nature Communications that nicotinamide riboside supplementation was well tolerated and increased NAD-related metabolites in healthy middle-aged and older adults, but the trial did not prove longer lifespan or fewer heart attacks (Martens et al., 2018). That distinction matters when a patient brings a NAD result of 42 µM and asks whether it means they are aging badly.

Kantesti reads a NAD result as an experimental marker and checks for safer adjacent clues: fasting glucose, HbA1c, ALT, creatinine, B12, folate and medication history. If you are considering supplement pathways, our NAC and glutathione guide shows why redox-related labs need safety context.

NAD-forløpere: hva et blodresultat ikke kan bevise

The evidence here is honestly mixed. Some human studies show increases in NAD metabolites, while hard outcomes such as mortality, dementia prevention and cardiovascular events remain unproven for NAD precursors.

Lab safety still matters. A patient taking 1000 mg/day of a NAD precursor who also has ALT of 72 U/L, eGFR of 54 mL/min/1.73 m² and new fatigue deserves a medication and supplement review before dose escalation.

Supplements also interact through methylation, liver metabolism and renal clearance. Before stacking products, patients should compare ingredients and timing using a safety-first resource such as our guide on supplement combinations.

Standardlaboratorier som ofte presterer bedre enn biologisk alder-score

HbA1c of 5.7-6.4% is the usual prediabetes range, and HbA1c of 6.5% or higher on repeat testing supports diabetes diagnosis. That single fact often changes food, medication and follow-up plans more reliably than a biological age score.

ApoB is another underused marker. An ApoB above 130 mg/dL often indicates high atherogenic particle burden, while lower targets such as below 80 mg/dL or below 65 mg/dL may be used for higher-risk patients depending on guideline context.

Kantesti er en AI blood test interpretation platform that prioritizes these actionable markers before ranking experimental longevity tests. For people deciding what to order first, our wellness panel guide separates useful labs from marketing noise.

Hvorfor trendanalyse slår én enkelt biologisk alder-verdi

Most lab reference intervals are population ranges, not personal baselines. A ferritin drop from 80 to 22 ng/mL in a menstruating adult may be clinically relevant months before hemoglobin falls below 12 g/dL.

Kantesti AI interprets trends by comparing prior results, units, timing, sex, age and context rather than treating a flag as the whole story. This is one reason our trend workflow is useful for patients tracking slow lab changes over years.

The practical move is simple: repeat the same marker at the same lab when possible and record major context changes. Weight loss, marathon training, statin initiation, menopause, shift work and infection can all move longevity-relevant markers within 4-12 weeks.

Virkelighetsnære scenarier som endrer tolkningen

A 39-year-old endurance athlete with AST 88 U/L, CK 1400 U/L and normal bilirubin is not the same as a sedentary patient with AST 88 U/L, ALT 110 U/L and GGT 95 U/L. Exercise timing can explain muscle-related enzyme shifts, as shown in our runner blood test guide.

A 54-year-old in menopause with rising LDL-C, ApoB and HbA1c may see a glycan age shift at the same time. The risk conversation should include body composition, sleep, alcohol, blood pressure and the lipid changes we cover in menopause lab trends.

An 82-year-old with low creatinine, low albumin and low IGF-1 may look metabolically clean because muscle mass is low. In older adults, low creatinine can hide frailty rather than prove excellent kidney health.

Enheter, referanseområder og hvorfor laboratorier er uenige

IGF-1 may appear in ng/mL or nmol/L, and conversion depends on molecular assumptions used by the reporting system. NAD metabolites may be reported as µM, nmol/g tissue, relative abundance or a proprietary score.

Routine labs are not immune either. Creatinine can be reported in mg/dL or µmol/L, glucose in mg/dL or mmol/L, and cholesterol in mg/dL or mmol/L; a glucose of 100 mg/dL equals about 5.6 mmol/L.

Before reacting to a trend, check units and lab source. Our guide to ulike laboratorieenheter is one of the fastest ways to avoid a false alarm.

Slik bestiller du en fornuftig panel for lang levetid

Fasting is useful when triglycerides, fasting glucose, insulin or HOMA-IR are being interpreted. Triglycerides below 150 mg/dL are usually considered normal, while values above 200 mg/dL can distort calculated LDL-C and change cardiovascular interpretation.

If you add glycan age, IGF-1 or NAD, write down sleep, exercise, infection, supplements, alcohol intake and medication changes during the prior 2 weeks. That small note often explains more than another expensive marker.

Patients often ask whether to test everything at once. I usually prefer a staged plan: establish the standard baseline first, fix obvious problems for 8-12 weeks, then decide whether emerging markers add value; our fasting checklist helps avoid preventable pre-test errors.

Slik leser Kantesti AI langlevdhetspaneler på en trygg måte

Kantesti er en AI-plattform for tolkning av biomarkører used by patients in 127+ countries, and our model is trained to avoid overcalling isolated longevity markers. A high glycan age with normal hs-CRP, normal HbA1c and stable lipids gets a different interpretation than the same glycan result with ApoB 145 mg/dL and ALT 86 U/L.

Our AI reads more than 15,000 biomarker names and unit variants, including scanned PDFs and phone photos, then flags patterns for follow-up in about 60 seconds. The engineering approach behind this workflow is explained in our technology guide.

The validation mindset matters. In a pre-registered benchmark of 100,000 anonymised blood test cases, the Kantesti AI Engine was evaluated across seven medical specialties with hyperdiagnosis trap cases, and the publication is available through the clinical benchmark DOI.

Konklusjon: bruk fremvoksende markører uten å overdrive

The safest interpretation order is simple: rule out actionable standard risks first, then ask whether the emerging marker agrees. If HbA1c is 6.1%, ApoB is 132 mg/dL and hs-CRP is 4.2 mg/L, those findings deserve attention regardless of whether a biological age score looks young.

Thomas Klein, MD, and our medical reviewers discourage using any single lab to make supplement, hormone or fasting decisions. Readers who want to understand physician oversight can review Kantesti's medisinske rådgivende styre and compare recommendations with their own clinician.

Kantesti research publications relevant to this article include: Kantesti Ltd. (2026). Women's Health Guide: Ovulation, Menopause & Hormonal Symptoms. Figshare. https://doi.org/10.6084/m9.figshare.31830721; and Kantesti Ltd. (2026). Clinical Validation of the Kantesti AI Engine (2.78T) on 100,000 Anonymised Blood Test Cases Across 127 Countries. Figshare. https://doi.org/10.6084/m9.figshare.32095435.

Frequently Asked Questions